Chimerization and characterization of a monoclonal antibody with potent neutralizing activity across multiple influenza A H5N1 clades

Antiviral Research

Volumn 107, Issue 1, 2014, Pages 76-83

  Mak, Tze Minn ^a   Hanson, Brendon J ^b   Tan, Yee Joo ^c,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DSO NATIONAL LABORATORIES   (Singapore)

^c INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Hemagglutinin; Influenza H5N1; Neutralizing monoclonal antibodies

Indexed keywords

EPITOPE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN A1 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 9F4; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; RECOMBINANT PROTEIN; VIRUS ANTIBODY;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CHIMERA; CONTROLLED STUDY; DRUG POTENCY; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; INFECTION PREVENTION; INFLUENZA VIRUS A H5N1; MDCK CELL LINE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS ENTRY; VIRUS STRAIN; ANIMAL; GENETICS; IMMUNOLOGY; INFLUENZA; MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MICE; RECOMBINANT PROTEINS;

EID: 84901044594     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.04.011     Document Type: Article

References (50)

1. A.N. Abdel-Ghafar, T. Chotpitayasunondh, Z. Gao, F.G. Hayden, D.H. Nguyen, M.D. de Jong, A. Naghdaliyev, J.S. Peiris, N. Shindo, S. Soeroso, and T.M. Uyeki Update on avian influenza A (H5N1) virus infection in humans N. Engl. J. Med. 358 3 2008 261 273
2. R. Burioni, F. Canducci, N. Mancini, N. Clementi, M. Sassi, D. De Marco, R.A. Diotti, D. Saita, M. Sampaolo, G. Sautto, M. Pianezze, and M. Clementi Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin influenza virus (S-OIV) Virology 399 1 2010 144 152
3. D.B. Burlington, M.L. Clements, G. Meiklejohn, M. Phelan, and B.R. Murphy Hemagglutinin-specific antibody responses in immunoglobulin G, A, and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus Infect. Immun. 41 2 1983 540 545 (Pubitemid 13075234)
4. Z. Cao, J. Meng, X. Li, R. Wu, Y. Huang, and Y. He The epitope and neutralization mechanism of AVFluIgG01, a broad-reactive human monoclonal antibody against H5N1 influenza virus PLoS One 7 5 2012 25
5. D.L. Chao, J.D. Bloom, B.F. Kochin, R. Antia, and I.M. Longini Jr. The global spread of drug-resistant influenza J. R. Soc. Interface 9 69 2012 648 656
6. H. Chen, Y. Li, Z. Li, J. Shi, K. Shinya, G. Deng, Q. Qi, G. Tian, S. Fan, H. Zhao, Y. Sun, and Y. Kawaoka Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China J. Virol. 80 12 2006 5976 5983 (Pubitemid 43849175)
7. D. Corti, J. Voss, S.J. Gamblin, G. Codoni, A. Macagno, D. Jarrossay, S.G. Vachieri, D. Pinna, A. Minola, F. Vanzetta, C. Silacci, B.M. Fernandez-Rodriguez, G. Agatic, S. Bianchi, I. Giacchetto-Sasselli, L. Calder, F. Sallusto, P. Collins, L.F. Haire, N. Temperton, J.P. Langedijk, J.J. Skehel, and A. Lanzavecchia A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins Science 333 6044 2011 850 856
8. L. Du, L. Jin, G. Zhao, S. Sun, J. Li, H. Yu, Y. Li, B.J. Zheng, R.C. Liddington, Y. Zhou, and S. Jiang Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin J. Virol. 87 4 2013 2215 2225
9. F. Ehrenmann, Q. Kaas, and M.P. Lefranc IMGT/3Dstructure-DB and IMGT/DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF Nucleic Acids Res. 38 database issue 2010 9
10. A. Frey, J. Di Canzio, and D. Zurakowski A statistically defined endpoint titer determination method for immunoassays J. Immunol. Methods 221 1-2 1998 35 41 (Pubitemid 29017921)
11. J.M. Garcia, and J.C. Lai Production of influenza pseudotyped lentiviral particles and their use in influenza research and diagnosis: an update Expert Rev. Anti Infect. Ther. 9 4 2011 443 455
12. Y. Guan, and G.J. Smith The emergence and diversification of panzootic H5N1 influenza viruses Virus Res. 178 1 2013 35 43
13. B.J. Hanson, A.C. Boon, A.P. Lim, A. Webb, E.E. Ooi, and R.J. Webby Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice Respir. Res. 7 2006 126
14. S. Herfst, E.J. Schrauwen, M. Linster, S. Chutinimitkul, E. de Wit, V.J. Munster, E.M. Sorrell, T.M. Bestebroer, D.F. Burke, D.J. Smith, G.F. Rimmelzwaan, A.D. Osterhaus, and R.A. Fouchier Airborne transmission of influenza A/H5N1 virus between ferrets Science 336 6088 2012 1534 1541
15. H. Hu, J. Voss, G. Zhang, P. Buchy, T. Zuo, L. Wang, F. Wang, F. Zhou, G. Wang, C. Tsai, L. Calder, S.J. Gamblin, L. Zhang, V. Deubel, B. Zhou, J.J. Skehel, and P. Zhou A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses J. Virol. 86 6 2012 2978 2989
16. M. Imai, T. Watanabe, M. Hatta, S.C. Das, M. Ozawa, K. Shinya, G. Zhong, A. Hanson, H. Katsura, S. Watanabe, C. Li, E. Kawakami, S. Yamada, M. Kiso, Y. Suzuki, E.A. Maher, G. Neumann, and Y. Kawaoka Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets Nature 486 7403 2012 420 428
17. Q.M. Le, M. Kiso, K. Someya, Y.T. Sakai, T.H. Nguyen, K.H. Nguyen, N.D. Pham, H.H. Ngyen, S. Yamada, Y. Muramoto, T. Horimoto, A. Takada, H. Goto, T. Suzuki, Y. Suzuki, and Y. Kawaoka Avian flu: isolation of drug-resistant H5N1 virus Nature 437 7062 2005
18. M.T. Le, H.F. Wertheim, H.D. Nguyen, W. Taylor, P.V. Hoang, C.D. Vuong, H.L. Nguyen, H.H. Nguyen, T.Q. Nguyen, T.V. Nguyen, T.D. Van, B.T. Ngoc, T.N. Bui, B.G. Nguyen, L.T. Nguyen, S.T. Luong, P.H. Phan, H.V. Pham, T. Nguyen, A. Fox, C.V. Nguyen, H.Q. Do, M. Crusat, J. Farrar, H.T. Nguyen, M.D. de Jong, and P. Horby Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam PLoS One 3 10 2008 0003339
19. M.P. Limberis, V.S. Adam, G. Wong, J. Gren, D. Kobasa, T.M. Ross, G.P. Kobinger, A. Tretiakova, and J.M. Wilson Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza Sci. Transl. Med. 5 187 2013 3006299
20. F. Liu, P.L. Bergami, M. Duval, D. Kuhrt, M. Posner, and L. Cavacini Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120 AIDS Res. Hum. Retroviruses 19 7 2003 597 607 (Pubitemid 36903283)
21. T.C. Luke, E.M. Kilbane, J.L. Jackson, and S.L. Hoffman Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann. Intern. Med. 145 8 2006 599 609 (Pubitemid 46780940)
22. W. Meng, W. Pan, A.J. Zhang, Z. Li, G. Wei, L. Feng, Z. Dong, C. Li, X. Hu, C. Sun, Q. Luo, K.Y. Yuen, N. Zhong, and L. Chen Rapid generation of human-like neutralizing monoclonal antibodies in urgent preparedness for influenza pandemics and virulent infectious diseases PLoS One 8 6 2013
23. E.L. Nason, J.D. Wetzel, S.K. Mukherjee, E.S. Barton, B.V. Prasad, and T.S. Dermody A monoclonal antibody specific for reovirus outer-capsid protein sigma3 inhibits sigma1-mediated hemagglutination by steric hindrance J. Virol. 75 14 2001 6625 6634 (Pubitemid 32578182)
24. C.D. O'Donnell, L. Vogel, A. Wright, S.R. Das, J. Wrammert, G.M. Li, M. Causland, N.Y. Zheng, J.W. Yewdell, R. Ahmed, P.C. Wilson, and K. Subbarao Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice mBio 3 3 2012 00120-12
25. H.L. Oh, S. Akerstrom, S. Shen, S. Bereczky, H. Karlberg, J. Klingstrom, S.K. Lal, A. Mirazimi, and Y.J. Tan An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses J. Virol. 84 16 2010 8275 8286
26. D.U. Pfeiffer, M.J. Otte, D. Roland-Holst, K. Inui, N. Tung, and D. Zilberman Implications of global and regional patterns of highly pathogenic avian influenza virus H5N1 clades for risk management Vet. J. 190 3 2011 309 316
27. M. Prabakaran, N. Prabhu, F. He, Q. Hongliang, H.T. Ho, J. Qiang, T. Meng, M. Goutama, and J. Kwang Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants PLoS One 4 5 2009
28. K.B. Renegar, P.A. Small Jr., L.G. Boykins, and P.F. Wright Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract J. Immunol. 173 3 2004 1978 1986 (Pubitemid 38971634)
29. C.W. Seibert, S. Rahmat, J.C. Krause, D. Eggink, R.A. Albrecht, P.H. Goff, F. Krammer, J.A. Duty, N.M. Bouvier, A. Garcia-Sastre, and P. Palese Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs J. Virol. 87 14 2013 7793 7804
30. N. Sirinonthanawech, M. Uiprasertkul, O. Suptawiwat, and P. Auewarakul Viral load of the highly pathogenic avian influenza H5N1 virus in infected human tissues J. Med. Virol. 83 8 2011 1418 1423
31. Y.A. Smirnov, A.S. Lipatov, A.K. Gitelman, Y. Okuno, R. Van Beek, A.D. Osterhaus, and E.C. Claas An epitope shared by the hemagglutinins of H1, H2, H5, and H6 subtypes of influenza A virus Acta Virol. 43 4 1999 237 244 (Pubitemid 29430389)
32. L. Sun, X. Lu, C. Li, M. Wang, Q. Liu, Z. Li, X. Hu, J. Li, F. Liu, Q. Li, J.A. Belser, K. Hancock, Y. Shu, J.M. Katz, M. Liang, and D. Li Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses PLoS One 4 5 2009 7
33. S. Tamura, T. Tanimoto, and T. Kurata Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines Jpn. J. Infect. Dis. 58 4 2005 195 207 (Pubitemid 41460922)
34. J.W. Tang, K.L. Ngai, J.C. Wong, W.Y. Lam, and P.K. Chan Emergence of adamantane-resistant influenza A(H3N2) viruses in Hong Kong between 1997 and 2006 J. Med. Virol. 80 5 2008 895 901 (Pubitemid 351500039)
35. T. Tanimoto, A.M. Haredy, N. Takenaka, S. Tamura, Y. Okuno, Y. Mori, K. Yamanishi, and S. Okamoto Comparison of the cross-reactive anti-influenza neutralizing activity of polymeric and monomeric IgA monoclonal antibodies Viral. Immunol. 25 5 2012 433 439
36. J. ter Meulen, E.N. van den Brink, L.L. Poon, W.E. Marissen, C.S. Leung, F. Cox, C.Y. Cheung, A.Q. Bakker, J.A. Bogaards, E. van Deventer, W. Preiser, H.W. Doerr, V.T. Chow, J. de Kruif, J.S. Peiris, and J. Goudsmit Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants PLoS Med. 3 7 2006
37. M. Uiprasertkul, P. Puthavathana, K. Sangsiriwut, P. Pooruk, K. Srisook, M. Peiris, J.M. Nicholls, K. Chokephaibulkit, N. Vanprapar, and P. Auewarakul Influenza A H5N1 replication sites in humans Emerg. Infect. Dis. 11 7 2005 1036 1041 (Pubitemid 40880902)
38. P.A. Underwood Mapping of antigenic changes in the haemagglutinin of Hong Kong influenza (H3N2) strains using a large panel of monoclonal antibodies J. Gen. Virol. 62 Pt 1 1982 153 169 (Pubitemid 13239796)
39. T. Velkov, C. Ong, M.A. Baker, H. Kim, J. Li, R.L. Nation, J.X. Huang, M.A. Cooper, and S. Rockman The antigenic architecture of the hemagglutinin of influenza H5N1 viruses Mol. Immunol. 56 4 2013 705 719
40. G. Wang, D. Zhan, L. Li, F. Lei, B. Liu, D. Liu, H. Xiao, Y. Feng, J. Li, B. Yang, Z. Yin, X. Song, X. Zhu, Y. Cong, J. Pu, J. Wang, J. Liu, G.F. Gao, and Q. Zhu H5N1 avian influenza re-emergence of Lake Qinghai: phylogenetic and antigenic analyses of the newly isolated viruses and roles of migratory birds in virus circulation J. Gen. Virol. 89 Pt 3 2008 697 702
41. H. Wang, Z. Feng, Y. Shu, H. Yu, L. Zhou, R. Zu, Y. Huai, J. Dong, C. Bao, L. Wen, P. Yang, W. Zhao, L. Dong, M. Zhou, Q. Liao, H. Yang, M. Wang, X. Lu, Z. Shi, W. Wang, L. Gu, F. Zhu, Q. Li, W. Yin, W. Yang, D. Li, T.M. Uyeki, and Y. Wang Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China Lancet 371 9622 2008 1427 1434
42. R. Weltzin, and T.P. Monath Intranasal antibody prophylaxis for protection against viral disease Clin. Microbiol. Rev. 12 3 1999 383 393 (Pubitemid 29330135)
43. WHO Antigenic and genetic characteristics of influenza A(H5N1) viruses and candidate vaccine viruses developed for potential use in human vaccines Wkly. Epidemiol. Rec. 84 41 2009 432 436
44. WHO Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness Wkly. Epidemiol. Rec. 87 11 2012 97 108
45. WHO. (2014). Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO, 2003-2014.
46. D.C. Wiley, I.A. Wilson, and J.J. Skehel Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation Nature 289 5796 1981 373 378 (Pubitemid 11135143)
47. J.M. Woof, and M.W. Russell Structure and function relationships in IgA Mucosal Immunol. 4 6 2011 590 597
48. J. Ye, H. Shao, D. Hickman, M. Angel, K. Xu, Y. Cai, H. Song, R.A. Fouchier, A. Qin, and D.R. Perez Intranasal delivery of an IgA monoclonal antibody effective against sublethal H5N1 influenza virus infection in mice Clin. Vaccine Immunol. 17 9 2010 1363 1370
49. J. Ye, H. Shao, and D.R. Perez Passive immune neutralization strategies for prevention and control of influenza A infections Immunotherapy 4 2 2012 175 186
50. B. Zhou, N. Zhong, and Y. Guan Treatment with convalescent plasma for influenza A (H5N1) infection N. Engl. J. Med. 357 14 2007 1450 1451 (Pubitemid 47535608)